Retrospective single institution analysis of all patients undergoing sleeve lobectomy or pneumonectomy between 2000 and 2005. Seventyeight patients underwent pneumonectomy (65 patients -70 years, 13 patients )70 years) and 69 sleeve lobectomy (50 patients -70 years, 19 patients )70 years). Pre-existing co-morbidity, surgical indication and induction therapy was similarly distributed between treatment by age-groups. In patients -70 years, pneumonectomy and sleeve lobectomy resulted in a 30-day mortality of 3% vs. 0 and an overall complication rate of 26% vs. 44%, respectively. In patients )70 years, pneumonectomy and sleeve lobectomy resulted in a 30-day mortality of 15% vs. 0 and an overall complication rate of 23% vs. 32%. In both age groups, pneumonectomy was associated with more airway complications (NS) and a significantly higher postoperative loss of FEV than sleeve lobectomy (P-0.0001, P-0.03). Age per se did 
Introduction
A recently published meta-analysis has demonstrated no significant difference in postoperative morbidity, mortality, recurrence rate and survival after pneumonectomy and sleeve lobectomy in patients with NSCLC w1x. Since major resections are increasingly performed in elderly patients w2-5x, sleeve resections may be particularly useful in this age group in order to decrease the risk of postoperative mortality and complications while preserving lung function and quality of life. However, there are actually no data available which specifically compare the postoperative risk and loss of pulmonary function of pneumonectomy and sleeve lobectomy in different age populations.
In this retrospective single institution study of patients treated between 2000 and 2005, we assessed postoperative mortality, complications and loss of pulmonary function after pneumonectomy vs. sleeve resection in patients less than and in patients more than 70 years old.
Patients and methods
All patients qualifying for major pulmonary resection underwent preoperative pulmonary and cardiac evaluation according to the algorithm of Bolliger w6x and Miller w7x, respectively. Patients with predicted FEV and DLCO of 1 -80% underwent exercise testing and patients with VO 2 max of -20 mlykgymin had split function testing by ventilationyperfusion scan; resection was performed if a postoperative predicted VO max of G10 mlykgymin was 2 obtained. All patients )50 years and those with a history of heart disease underwent echocardiography and those with signs of ischemia myocardium scintigraphy or stress echocardiography. Resection was performed in the absence of signs of reversible ischaemia and preserved left ventricular function. Continuous peridural anaesthesia was offered to all patients in the absence of contraindications. Sleeve lobectomy was preferred to pneumonectomy whenever possible. If the extent of the disease required a pneumonectomy, resection was performed in the case of a postoperative predicted VO max of G10 mlykgymin and normal 2 echocardiography. All patients had muscle flap coverage of the bronchial stump or airway anastomosis. All patients underwent postoperative avoidance of fluid overload, prevention of atelectasis by early mobilisation and chest physiotherapy, and routine s.c. thrombo-prophylaxis. Patients with pneumonectomy had postoperative oral anticoagulation for three months. Non-small cell lung cancer.
1 Table 2 Postoperative 30-day mortality and complication rate after pneumonectomy and sleeve lobectomy in patients -70 years of age 
Follow-up
The charts of all patients undergoing sleeve lobectomy or pneumonectomy between 1 January 2000 and 30 June 2005 were revisited. Pre-existing co-morbidities, indications for surgery, induction therapy and side of pneumonectomy were noted for each patient as well as 30-day mortality and major postoperative morbidity including pneumonia, myocardial infarction, congestive heart failure, pulmonary embolism, cerebro-vascular accidents, airway dehiscence, broncho-pleural fistula, empyema or infections of the thoracotomy site. Minor complications were excluded such as atelectasis requiring -2 bronchoscopies, non-infected pleural effusion, residual air space, infections at the site of chest tubes and arrhythmias responding to medical therapy w8x. Postoperative pulmonary function testing (FEV , DLCO) performed between 3 and 6 months after the 1 operation were recorded and were compared to preoperative values.
Statistical analysis
The x and Fisher's exact-test were used to determine 2 differences in proportions. The Wilcoxon test was used to test the differences in loss of FEV and DLCO. Two-sided 1 P-values -0.05 were considered significant.
Results
One hundred and forty-three patients underwent pneumonectomy or sleeve resection at our institution between 1 January 2000 and 30 June 2005. Seventy-eight patients underwent pneumonectomy, 65 patients were younger and 13 patients older than 70 years at the time of operation. Sixty-nine patients underwent sleeve lobectomy, 50 patients were younger and 19 older than 70 years. NSCLC was the predominant indication for surgery accounting for 77% and 79% of patients requiring pneumonectomy and sleeve lobectomy, respectively. Pathological stage I, II and III NSCLC was found in 36%, 27% and 36% of patients requiring pneumonectomy, and 22%, 44% and 33% of patients requiring sleeve lobectomy (NS). Table 1 shows the distribution of pre-existing COPD, coronary artery disease, obesity and induction therapy for each of the four treatments by age-groups. There were no significant differences for these variables between the four groups. For patients undergoing pneumonectomy, a right-sided procedure was more frequently performed in patients -70 years (Ps0.03). The preoperative predicted FEV and DLCO were 1 79.5"19.5% and 72.8"20.9% in patients -70 years, and 80.5"21.3% and 72"20.8% in patients )70 years, respectively, without significant difference between both age groups. Table 2 indicates the 30-day mortality and the complications after pneumonectomy and sleeve lobectomy in patients -70 years. Pneumonectomy and sleeve lobectomy resulted in a 30-day mortality of 3% vs. 0 (Ps0.5) and an overall complication rate of 26% vs. 44% (Ps0.05). Two patients died after pneumonectomy, one from myocardial infarction and one from broncho-pleural fistula associated with multiorgan failure. Pneumonectomy was associated with more cardiac complications (NS) and broncho-pleural fistulas (NS), and sleeve lobectomy with more pulmonary complications (Ps0.01). Table 3 shows the 30-day mortality and the complications after pneumonectomy and sleeve lobectomy in patients )70 years. Pneumonectomy and sleeve lobectomy resulted in a 30-day mortality rate of 15% vs. 0 (Ps0.2) and an overall complication rate of 23% vs. 32% (Ps0.7). Two patients died after pneumonectomy, one from pneumonia and one from broncho-pleural fistula and ARDS. Pulmonary and cardiac complications were more frequent after sleeve lobectomy than after pneumonectomy (NS) and the incidence of airway dehiscence (BPF) was higher after pneumonectomy than after sleeve lobectomy (NS). Table 4 shows the differences in preoperative and postoperative predicted FEV and DLCO for each treatment 1 group. There was a significant difference between preoperative and postoperative FEV and DLCO values for both 1 procedures in both age groups (P-0.05), except for FEV 1 in patients )70 years undergoing sleeve lobectomy (NS). In patients -70 years, the postoperative loss of FEV and 1 DLCO were significantly higher after pneumonectomy than after sleeve lobectomy (P-0.0001, Ps0.008); in patients )70 years, the same holds true for FEV (Ps0.03) but not 1 for DLCO (NS). Patients -70 years undergoing pneumonectomy had a similar loss of FEV and DLCO as patients 1 )70 years undergoing pneumonectomy (NS). The same holds true for sleeve lobectomy (NS).
Postoperative mortality and complications

Postoperative loss of pulmonary function
Discussion
It has been shown that life expectancy of persons aged 70 and 80 years in western countries is 14 years and 8.6 years, respectively, and that at least 75% and 50% of the rest of their lives are spent living independently w9, 10x. Elderly patients are therefore no longer excluded from NSCLC surgery solely on the base of short life expectancy or decreased quality of life.
Although there is no definition of an elderly patient, individuals who are 70 years or older have decreased cardiopulmonary reserves and are at an increased risk of developing postoperative complications after lung resection w2x. However, several studies confirm the feasibility and the survival benefit of major resections in properly selected patients older than 70 years, with a reported postoperative mortality rate ranging from 1% to 21% w2-5x. This wide range of postoperative mortality may be related to differences in patient selection, peri-and postoperative management and the rate of pneumonectomy which varied from 0-29%. A review of the literature and a recently published case-control study revealed a postoperative mortality rate of 16-20% w11x and 11% w12x after pneumonectomy in patients )70 years, respectively, indicating that pneumonectomy should be avoided in the elderly whenever possible.
Sleeve lobectomy has gained increasing acceptance as an alternative to pneumonectomy in patients requiring resection for NSCLC. A recently published meta-analysis in this respect revealed a pooled postoperative mortality and complication rate for sleeve resection and pneumonectomy of 3.5% vs. 5.7% and 31% vs. 32%, respectively, without significant difference w1x. However, the mean age of the studied population ranged from 59 to 65 years for sleeve lobectomy and from 58 to 67 years for pneumonectomy. There is actually no study available assessing the risk of sleeve resection and pneumonectomy in specific age populations.
In this retrospective study, we compared 30-day mortality, major complications and loss of pulmonary function after sleeve resection vs. pneumonectomy in patients less than and in patients more than 70 years old. There was no significant difference in pre-existing co-morbidity, induction therapy and preoperative pulmonary function (FEV 1 and DLCO) between the treatment by age-groups.
Patients -70 years had a similar 30-day mortality after sleeve lobectomy and pneumonectomy (0 vs. 3%) which corresponds to those reported in the literature. Pneumonectomy was associated with more cardiac complications (5% vs. 0) and broncho-pleural fistulas (6% vs. 0), and sleeve lobectomy with more pulmonary complications (42% vs. 20%).
In patients )70 years, pneumonectomy resulted in a higher 30-day mortality rate than sleeve lobectomy (15% vs. 0). The high mortality rate after pneumonectomy in this age group was similar to that reported in the literature and may be related to induction therapy and right-sided procedures which are both known to increase the mortality after pneumonectomy. In addition, 8% of the patients with pneumonectomy developed a broncho-pleural fistula, whereas no airway complications were observed after sleeve lobectomy in this age group.
There are actually no data available comparing the loss of pulmonary function after pneumonectomy and sleeve lobectomy in different age populations. In our series, pneumonectomy was associated with a significantly higher postoperative loss of FEV than sleeve lobectomy in both 1 age groups. However, age per se did not influence the loss of pulmonary function for a given type of resection: patients -70 years undergoing pneumonectomy had a similar loss of FEV and DLCO with patients )70 years under-1 going pneumonectomy and the same holds true for sleeve lobectomy.
In conclusion, our results suggest that sleeve resections may bear a therapeutic advantage compared to pneumonectomy, especially in elderly patients, but further studies with larger sized treatment by age-groups are necessary to confirm these results.
